Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases

doi:10.1002/hep.31884

Practice Guideline

. 2021 Aug;74(2):1014-1048.

doi: 10.1002/hep.31884.

Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases

Scott W Biggins¹, Paulo Angeli², Guadalupe Garcia-Tsao^{3

4}, Pere Ginès^{5

6}, Simon C Ling⁷, Mitra K Nadim⁸, Florence Wong⁹, W Ray Kim¹⁰

Affiliations

¹ Division of Gastroenterology and Hepatology, and Center for Liver Investigation Fostering discovEryUniversity of WashingtonSeattleWA.
² Unit of Hepatic Emergencies and Liver TransplantationDepartment of MedicineDIMEDUniversity of PadovaPaduaItaly.
³ Department of Internal MedicineSection of Digestive DiseasesYale UniversityNew HavenCT.
⁴ VA-CT Healthcare SystemWest HavenCT.
⁵ Liver Unit, Hospital Clinic, and Institut d'Investigacions Biomèdiques August Pi i SunyerUniversity of BarcelonaBarcelonaSpain.
⁶ Centro de Investigación Biomèdica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD)MadridSpain.
⁷ The Hospital for Sick Children, Division of Gastroenterology, Hepatology and Nutrition, and Department of PaediatricsUniversity of TorontoTorontoOntarioCanada.
⁸ Division of NephrologyUniversity of Southern CaliforniaLos AngelesCA.
⁹ Division of Gastroenterology and HepatologyUniversity Health NetworkUniversity of TorontoTorontoOntarioCanada.
¹⁰ Division of Gastroenterology and HepatologyStanford UniversityPalo AltoCA.

PMID: 33942342
DOI: 10.1002/hep.31884

Practice Guideline

Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases

Scott W Biggins et al. Hepatology. 2021 Aug.

. 2021 Aug;74(2):1014-1048.

doi: 10.1002/hep.31884.

Authors

Scott W Biggins¹, Paulo Angeli², Guadalupe Garcia-Tsao^{3

4}, Pere Ginès^{5

6}, Simon C Ling⁷, Mitra K Nadim⁸, Florence Wong⁹, W Ray Kim¹⁰

Affiliations

¹ Division of Gastroenterology and Hepatology, and Center for Liver Investigation Fostering discovEryUniversity of WashingtonSeattleWA.
² Unit of Hepatic Emergencies and Liver TransplantationDepartment of MedicineDIMEDUniversity of PadovaPaduaItaly.
³ Department of Internal MedicineSection of Digestive DiseasesYale UniversityNew HavenCT.
⁴ VA-CT Healthcare SystemWest HavenCT.
⁵ Liver Unit, Hospital Clinic, and Institut d'Investigacions Biomèdiques August Pi i SunyerUniversity of BarcelonaBarcelonaSpain.
⁶ Centro de Investigación Biomèdica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD)MadridSpain.
⁷ The Hospital for Sick Children, Division of Gastroenterology, Hepatology and Nutrition, and Department of PaediatricsUniversity of TorontoTorontoOntarioCanada.
⁸ Division of NephrologyUniversity of Southern CaliforniaLos AngelesCA.
⁹ Division of Gastroenterology and HepatologyUniversity Health NetworkUniversity of TorontoTorontoOntarioCanada.
¹⁰ Division of Gastroenterology and HepatologyStanford UniversityPalo AltoCA.

PMID: 33942342
DOI: 10.1002/hep.31884

No abstract available

PubMed Disclaimer

Comment in

In search of a roadmap towards improving care of patients with cirrhosis and ascites, could a platform trial design transform clinical research?
O'Brien A. O'Brien A. Hepatobiliary Surg Nutr. 2022 Dec;11(6):889-892. doi: 10.21037/hbsn-22-478. Hepatobiliary Surg Nutr. 2022. PMID: 36523931 Free PMC article. No abstract available.
Ascites and complications: getting to the root of the trouble.
Mandorfer M, Simbrunner B. Mandorfer M, et al. Hepatobiliary Surg Nutr. 2023 Feb 28;12(1):124-127. doi: 10.21037/hbsn-22-625. Epub 2023 Jan 6. Hepatobiliary Surg Nutr. 2023. PMID: 36860249 Free PMC article. No abstract available.

Cited by

SGLT2 Inhibitors in Cirrhosis: A Promising Therapeutic Avenue with Potential Risks.
Loyola-Vélez AJ, John BV. Loyola-Vélez AJ, et al. Dig Dis Sci. 2024 Nov 24. doi: 10.1007/s10620-024-08703-3. Online ahead of print. Dig Dis Sci. 2024. PMID: 39581899 No abstract available.
Spontaneous Bacterial Peritonitis Complicated by Loculations Requiring Alteplase.
Lucioni T. Lucioni T. Cureus. 2024 Oct 14;16(10):e71456. doi: 10.7759/cureus.71456. eCollection 2024 Oct. Cureus. 2024. PMID: 39539884 Free PMC article.
Optimal threshold of portal pressure gradient for patients with ascites after covered TIPS: a multicentre cohort study.
Xia Y, Tie J, Wang G, Wu H, Zhuge Y, Yuan X, Huang G, Li Z, Zhang L, Cai Z, Tang C, Zhang C. Xia Y, et al. Hepatol Int. 2024 Nov 9. doi: 10.1007/s12072-024-10742-x. Online ahead of print. Hepatol Int. 2024. PMID: 39521751
In-person prospective audit and feedback on an oncology ward: development of an immunocompromised antimicrobial stewardship program.
Imlay H, Greenlee SB, Tritle BJ, Fino NF, Spivak ES. Imlay H, et al. Antimicrob Steward Healthc Epidemiol. 2024 Oct 15;4(1):e173. doi: 10.1017/ash.2024.446. eCollection 2024. Antimicrob Steward Healthc Epidemiol. 2024. PMID: 39430797 Free PMC article.
Safety and Efficacy of Dapagliflozin in Recurrent Ascites: A Pilot Study.
Singh V, De A, Aggrawal R, Singh A, Charak S, Bhagat N. Singh V, et al. Dig Dis Sci. 2024 Oct 9. doi: 10.1007/s10620-024-08667-4. Online ahead of print. Dig Dis Sci. 2024. PMID: 39384712

See all "Cited by" articles

References

1. Runyon BA, AASLD . Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012. Hepatology 2013;57:1651‐1653.
1. D'Amico G, Garcia‐Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 2006;44:217‐231.
1. Ginés P, Quintero E, Arroyo V, Terés J, Bruguera M, Rimola A, et al. Compensated cirrhosis: natural history and prognostic factors. Hepatology 1987;7:122‐128.
1. Pant C, Jani BS, Desai M, Deshpande A, Pandya P, Taylor R, et al. Hepatorenal syndrome in hospitalized patients with chronic liver disease: results from the Nationwide Inpatient Sample 2002‐2012. J Investig Med 2016;64:33‐38.
1. Arroyo V, Fernandez J. Pathophysiological basis of albumin use in cirrhosis. Ann Hepatol 2011;10(Suppl. 1):S6‐S14.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations

[1] Runyon BA, AASLD . Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012. Hepatology 2013;57:1651‐1653.

[2] Runyon BA, AASLD . Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012. Hepatology 2013;57:1651‐1653.

[3] D'Amico G, Garcia‐Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 2006;44:217‐231.

[4] D'Amico G, Garcia‐Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 2006;44:217‐231.

[5] Ginés P, Quintero E, Arroyo V, Terés J, Bruguera M, Rimola A, et al. Compensated cirrhosis: natural history and prognostic factors. Hepatology 1987;7:122‐128.

[6] Ginés P, Quintero E, Arroyo V, Terés J, Bruguera M, Rimola A, et al. Compensated cirrhosis: natural history and prognostic factors. Hepatology 1987;7:122‐128.

[7] Pant C, Jani BS, Desai M, Deshpande A, Pandya P, Taylor R, et al. Hepatorenal syndrome in hospitalized patients with chronic liver disease: results from the Nationwide Inpatient Sample 2002‐2012. J Investig Med 2016;64:33‐38.

[8] Pant C, Jani BS, Desai M, Deshpande A, Pandya P, Taylor R, et al. Hepatorenal syndrome in hospitalized patients with chronic liver disease: results from the Nationwide Inpatient Sample 2002‐2012. J Investig Med 2016;64:33‐38.

[9] Arroyo V, Fernandez J. Pathophysiological basis of albumin use in cirrhosis. Ann Hepatol 2011;10(Suppl. 1):S6‐S14.

[10] Arroyo V, Fernandez J. Pathophysiological basis of albumin use in cirrhosis. Ann Hepatol 2011;10(Suppl. 1):S6‐S14.

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases

Affiliations

Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases

Authors

Affiliations

Comment in

Similar articles

Cited by

References

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

Comment in

Similar articles

Cited by

References

Publication types

MeSH terms

Related information

LinkOut - more resources

Full Text Sources

Other Literature Sources